BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1699188)

  • 1. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
    Albright SG; Warner AA; Seeds JW; Burton BK
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of congenital nephrosis by in utero kidney biopsy.
    Wapner RJ; Jenkins TM; Silverman N; Kaufmann M; Hannau C; McCue P
    Prenat Diagn; 2001 Apr; 21(4):256-61. PubMed ID: 11288113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P; Robinson L; Tabsh K; Crandall BF
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated MSAFP levels and congenital heart defects: lack of an association.
    Albar H; MacDonald KM; Harman CR; Evans JA; Chodirker BN
    Am J Med Genet; 1994 Feb; 49(3):337-40. PubMed ID: 7516120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine prenatal screening policy of fetal malformations by both maternal serum alpha-fetoprotein and ultrasound in eastern Hungary.
    Szabó M; Tóth Z; Török O; Veress L; Bede E; Nagy E; Papp Z
    Acta Chir Hung; 1989; 30(4):291-8. PubMed ID: 2484200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD; Owen J; Davis RO; Brumfield CG
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
    Ryynänen M; Seppälä M; Kuusela P; Rapola J; Aula P; Seppä A; Jokela V; Castren O
    Br J Obstet Gynaecol; 1983 May; 90(5):437-42. PubMed ID: 6189511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital nephrosis: detection of index cases through maternal serum alpha-fetoprotein screening.
    Hogge WA; Hogge JS; Schnatterly PT; Sun CJ; Blitzer MG
    Am J Obstet Gynecol; 1992 Nov; 167(5):1330-3. PubMed ID: 1279976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
    Burton BK
    Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
    Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
    Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of congenital nephrosis in 23 high-risk families.
    Aula P; Rapola J; Karjalainen O; Lindgren J; Hartikainen AL; Seppälä M
    Am J Dis Child; 1978 Oct; 132(10):984-7. PubMed ID: 82399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations.
    Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
    Prenat Diagn; 1996 Jul; 16(7):635-9. PubMed ID: 8843473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.